Welcure Drugs & Pharmaceuticals Ltd.

4.85 +0.23 ▲5.0%

23 April 2024, 04:01:00 PM
Volume: 48,189

Company Profile

Sector Trading Sector Icon Trading Compare with Sector peers
Industry Trading Industry Icon Trading Compare with Industry peers
Website http://www.welcuredrugs.com
Market Cap 6.55 Cr.
Enterprise Value(EV) 6.24 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.01 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 595.76 Trailing Twelve Months Ending 2023-12
Industry PE 64.26 Trailing Twelve Months Ending 2023-12
Book Value / Share 1.06 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.58 Calculated using Price: 4.85
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.35 Cr. 13,512,100 Shares
FaceValue 10
About Welcure Drugs & Pharmaceuticals Ltd.
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992.

Welcure Drugs & Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Welcure Drugs & Pharmaceuticals Ltd. Performance

1 Day
+4.98%
1 Week
+2.97%
1 Month
+21.55%
3 Month
+10.23%
6 Month
+25.97%
1 Year
+24.36%
2 Year
-45.87%
5 Year
+931.91%
10 Year
+380.20%

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 0 108.61 -65.8 17.83 -49.46 131.74 29.03 12.65
Return on Capital Employed (%) 0 0 108.91 -65.46 18.22 -48.94 131.94 29.12 12.67
Return on Assets (%) 10.4 227.41 94.5 -58.62 14.57 -34.54 112.99 27.77 12.51

Welcure Drugs & Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 0 0 0 0 0 0 0 2 1
Non Curr. Liab.
Curr. Liab. 0 0 0 0 0
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 2 1
Non Curr. Assets 0 2 1
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 2 1

Welcure Drugs & Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 0 0 0 0 0 0 0 0
Other Income 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0
Interest
Depreciation 0
Taxation
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0

Welcure Drugs & Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 1
Cash Fr. Finan. -1
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Welcure Drugs & Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 14.12 14.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 85.88 85.88 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Welcure Drugs & Pharmaceuticals Ltd. Announcements

Fri, 19 Apr 2024
Submission Of Certificate Under Regulation 40 (9) Of SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015 For The Year Ended 31Stmarch 2024
Compliance of Regulation 40 (9) of SEBI (LODR) Regulation 2015
Sat, 13 Apr 2024
Compliance Certificate For The Period March 2024
Compliance Certificate under Regulation 7(3)
Fri, 12 Apr 2024
Submission Of Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Compliance regarding Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015

Welcure Drugs & Pharmaceuticals Ltd. Technical Scans

Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months

Welcure Drugs & Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 349,364.74 3,065.10 +0.1%
Redington Ltd. 17,027.05 218.10 +0.1%
Honasa Consumer Ltd. 13,109.19 437.70 +8.2%
MMTC Ltd. 10,876.50 74.85 +3.2%
Entero Healthcare Solutions Ltd. 4,967.42 1,204.05 +5.2%
Lloyds Enterprises Ltd. 4,226.00 34.88 +5.0%
Veritas (India) Ltd. 3,785.17 1,440.05 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-12 99.46 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-12 14.15 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 437.70 +8.2%
MMTC Ltd. Consolidated 2023-12 82.24 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-12 33.27 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-12 19.75 1,440.05 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-12 9.05 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-12 2.35 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 19.91 437.70 +8.2%
MMTC Ltd. Consolidated 2023-12 7.40 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 3.17 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-12 2.79 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-12 1.53 1,440.05 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 1.16 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-03 0.45 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.01 437.70 +8.2%
MMTC Ltd. Consolidated 2023-03 0.14 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.63 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-03 0.06 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 0.10 1,440.05 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-03 22.66 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 437.70 +8.2%
MMTC Ltd. Consolidated 2023-03 247.70 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 4.30 1,440.05 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-03 22.66 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 437.70 +8.2%
MMTC Ltd. Consolidated 2023-03 247.70 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 0.00 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 4.30 1,440.05 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 136,977.76 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-03 79,376.78 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 1,492.75 437.70 +8.2%
MMTC Ltd. Consolidated 2023-03 3,528.18 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 3,300.21 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-03 380.30 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 2,163.22 1,440.05 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 2,208.94 3,065.10 +0.1%
Redington Ltd. Consolidated 2023-03 1,439.39 218.10 +0.1%
Honasa Consumer Ltd. Consolidated 2023-03 -150.97 437.70 +8.2%
MMTC Ltd. Consolidated 2023-03 1,562.27 74.85 +3.2%
Entero Healthcare Solutions Ltd. Consolidated 2023-03 -11.10 1,204.05 +5.2%
Lloyds Enterprises Ltd. Consolidated 2023-03 45.03 34.88 +5.0%
Veritas (India) Ltd. Consolidated 2023-03 94.81 1,440.05 +2.0%

Welcure Drugs & Pharmaceuticals Ltd. FAQ's

What is Welcure Drugs&Pharma share price?

Can I buy Welcure Drugs&Pharma shares now?

What is the Market Cap of Welcure Drugs&Pharma?

What are the key metrics to analyse Welcure Drugs&Pharma?

What is the 52 Week High and Low of Welcure Drugs&Pharma?

What is the trend of Welcure Drugs&Pharma share price?